Yes, bipolar disorder is widely understood as a spectrum condition rather than a simple either/or diagnosis. The formal diagnostic system recognizes several distinct types, but mood symptoms shade into one another in ways that don’t always fit neatly into boxes. Roughly 40 to 50 percent of people diagnosed with major depression also show some history of hypomanic features, suggesting that the boundary between “bipolar” and “not bipolar” is far blurrier than most people assume.
What the Bipolar Spectrum Looks Like
The current diagnostic manual (DSM-5) lists several recognized forms of bipolar disorder, each representing a different point on the spectrum. Bipolar I involves full manic episodes severe enough to seriously disrupt daily life or require hospitalization. Bipolar II involves hypomanic episodes, which share the same core symptoms (elevated mood, decreased need for sleep, racing thoughts, increased energy) but last at least four days rather than a full week and don’t cause the same level of impairment or psychosis. Then there’s cyclothymic disorder, defined by at least two years of fluctuating mood that never reaches the full threshold for mania or major depression but is present more days than not, with no stable stretch lasting longer than two consecutive months.
Beyond these three, the DSM-5 includes a catch-all category for bipolar presentations that don’t meet the strict criteria for any of the above. Someone might experience manic symptoms for only a few days, or have clear mood cycling that falls just short of the required symptom count. These presentations are real, clinically significant, and part of the spectrum.
The Concept Goes Deeper Than the Official Categories
Psychiatric researchers have pushed the spectrum idea much further than the diagnostic manual currently reflects. Hagop Akiskal, one of the most influential voices on the topic, proposed several additional subtypes. One is antidepressant-induced hypomania (sometimes called Bipolar III), where a person never experiences spontaneous mania but tips into a high when started on an antidepressant. Another involves people with severe, recurrent depression who have a first-degree family member with bipolar disorder, suggesting shared biology even without a personal history of mania.
Akiskal also highlighted the role of temperament. Some people live with a baseline personality that looks like constant, low-grade hypomania: high energy, talkativeness, confidence, reduced sleep need. This “hyperthymic temperament” isn’t episodic the way classic bipolar disorder is; it’s woven into who the person is. Similarly, cyclothymic temperament involves lifelong mood instability that colors everyday experience. These temperamental patterns are considered part of the bipolar spectrum even though they don’t involve discrete episodes.
Another important contribution came from Athanasio Koukopoulos, who described “mixed depression,” a state where depressive symptoms combine with features of excitation like racing thoughts, pressured speech, agitation, irritability, and impulsive suicidality. This kind of depression feels different from a quiet, low-energy depressive episode, and it often responds differently to treatment.
Mixed Features Blur the Line Between Mania and Depression
One of the strongest arguments for a spectrum model is the existence of mixed states. The DSM-5 introduced a “mixed features” specifier, officially acknowledging that manic and depressive symptoms can occur simultaneously rather than in clean, separate episodes. This was a deliberate shift away from treating mania and depression as opposite poles and toward viewing them as dimensions that can overlap.
In practice, a person in a manic or hypomanic episode can qualify for the mixed features label if they also experience at least three depressive symptoms during most of the episode, such as persistent sadness, loss of interest, fatigue, feelings of worthlessness, or thoughts of death. Going the other direction, a person in a depressive episode gets the mixed features label if they also show at least three manic or hypomanic symptoms, like racing thoughts, elevated mood, grandiosity, pressured speech, or a decreased need for sleep.
Mixed episodes are more than an academic distinction. They’re associated with higher suicide risk and tend to be harder to treat. Recognizing them depends on understanding that mood states aren’t binary, which is exactly what the spectrum model predicts.
Subthreshold Bipolarity Is Surprisingly Common
Perhaps the most striking evidence for a spectrum comes from research on people diagnosed with major depressive disorder. Multiple studies have found that approximately 40 percent of people with MDD have experienced subsyndromal hypomanic features at some point in their lives. These are periods of elevated energy, excitement, or overactivity that don’t quite meet the full diagnostic threshold for hypomania, either because they don’t last long enough, don’t include enough symptoms, or aren’t noticeable enough to others.
One large study found that when researchers loosened the strict interview criteria for hypomania just slightly (for example, counting fewer symptoms or shorter durations), roughly half of outpatients with depression could be reclassified as falling somewhere on the bipolar spectrum. This doesn’t mean those people were misdiagnosed. It means the line between unipolar depression and bipolar disorder is drawn somewhat arbitrarily, and many people sit right on that line.
Researchers have operationalized these “soft signs” of bipolarity in various ways: a history of at least one or two hypomanic symptoms, a first-degree relative with bipolar disorder, or a tendency to become activated or agitated on antidepressants. Individually, none of these features is enough for a bipolar diagnosis. Together, they suggest a shared biological vulnerability with full-threshold bipolar disorder.
Why This Matters for Diagnosis and Treatment
The spectrum concept isn’t just theoretical. Where someone falls on it can change what kind of treatment works best. Lithium, for example, is considered the gold standard for long-term maintenance in bipolar disorder and is more effective at preventing manic relapses than depressive ones. For severe manic episodes, antipsychotics and certain anticonvulsants tend to work faster. The choice between these options often depends on which end of the spectrum a person’s symptoms lean toward.
The bigger treatment implication involves people who don’t have an obvious bipolar diagnosis. Someone with recurrent depression who also has soft bipolar features (a family history of bipolar disorder, mixed depressive symptoms, a history of becoming agitated on antidepressants) may not respond well to standard antidepressant treatment. In fact, antidepressants can sometimes worsen their condition by triggering rapid cycling or mixed states. Recognizing where someone sits on the spectrum can steer clinicians toward mood stabilizers instead of, or alongside, antidepressants.
No Biomarker Confirms It Yet
Despite strong clinical evidence for a spectrum, there’s currently no blood test, brain scan, or genetic marker that can confirm where someone falls on it. The categorical system used in the DSM is not based on underlying biology; it’s based on observable patterns of symptoms and their duration. Interestingly, over a century ago, Emil Kraepelin, the psychiatrist who first described “manic-depressive insanity,” seemed to view mood disorders dimensionally rather than categorically. His original writings described a broad continuum of mood disturbance, an idea that modern researchers have circled back to.
Genetics research does hint at shared biology across the spectrum. Bipolar disorder and schizophrenia, for instance, share some genetic risk factors, and the same genetic variants appear across bipolar I, bipolar II, and recurrent depression at different frequencies. But the science hasn’t yet reached the point where it can carve the spectrum into biologically validated categories.
What this means in practical terms is that diagnosis still depends heavily on a careful clinical history: the pattern of your mood episodes, their severity and duration, your family history, and how you’ve responded to past treatments. If you’ve experienced any form of mood cycling, even brief or mild periods of unusual energy, reduced sleep, or uncharacteristic impulsivity, that history is worth mentioning to a clinician. It can change the diagnostic picture significantly.